AI 본문요약

엑셀 다운로드 AI-Helper

참고문헌 (43)

1. 3 Blindness diseases: diabetic retinopathy, macular degeneration, glaucoma. Health Josun. 2010;11:60. 

2. Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72. 

   상세보기

3. Lee KH, Noh SS. The study of the etiological cause of blurred vision and blindness. Daejun Univ Institution of oriental medicine. 4(1);1995:1-25. 

4. Chen YH, Bedell M, Zhang K. Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv. 2010. Oct;10(5):271-81. 

   상세보기

5. Seo CH, Kwon JN, Kim YK. Senial Macular Degeneration. A case report. J Korean Oriental Med. 2000;21(4):260-3. 

6. Park KH, Song SJ, Lee WK, Yoon HS, Koh HJ, Kim CG et al. The results of Nation-wide registry of age-related macular degeneration in Korea. J Korean Ophthalmol Soc. 2010;51(4) 516-23. 

   상세보기

7. Bressler NM. Early detection and treatment neovascular age-related macular degeneration. J Am Board Fam Pract. 2002(15):142-52. 

8. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degenerationemerging pathogenetic and therapeutic concepts. Ann Med. 2006;38:450-71. 

   상세보기

9. Smith W. Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continetns. J Ophthalmology. 2001;108:697-704. 

   상세보기

10. Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unravelling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisnms for age-related macular degeneration. Annu Rev Genomics Hum Genet. 2009;10:19-43. 

    상세보기

11. Hirvela H, Luukinen H, Laara E, Sc L, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. J Ophthalmology. 1996;103:871-7. 

    상세보기

12. Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy-The Beaver Dam Eye Study. 1998;147:103-10. 

    상세보기

13. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001;119:1191-9. 

    상세보기

14. Montezuma SR, Sobrin L, Seddon JM. Review of genetics in age related macular degeneration. Semin Ophthalmol. 2007;22:229-40. 

    상세보기

15. Klein R, Myers CE, Lee KE, Gangnon RE, Sivakumaran TA, Iyengar SK, et al. Small Drusen and Age-Related Macular Degeneration:The Beaver Dam Eye Study. J Clin Med. 2015 Mar;4(3):424-440. 

    상세보기

16. Han SY, Bae JH, Song SJ. Quaility of life assessment in patients with wet age-related macular degeneration. J Korean Ophthalmol Soc. 2012;53(4):528-35. 

    상세보기

17. Jung JW, Moon YS. Depression and anxiety in Korean patients with age-related macular degeneration. J Korean Opthalmol Soc. 2012;53(6):792-800. 

    상세보기

18. Göbel AP, Fleckenstein M, Schmitz-Valckenberg S, Brinkmann CK, Holz FG. Imaging geographic atrophy in age-related macular degeneration. Ophthalmologica. 2011;226:182-90. 

    상세보기

19. Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL 3rd, Klein ML, et al. Change in area of geographic atrophy in the age-related eye disease study:AREDS report No 26. Arch Ophthalmol. 2009;127:1168-74. 

    상세보기

20. Schmitz-Valckenberg S, Fleckenstein M, Göbel AP, Sehmi K, Fitzke FW, Holz FG, et al. Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy. Am J Ophthalmol. 2008 Aug;146(2):183-92. 

    상세보기

21. Haimovici R, Kramer M. Miller JW, et al. Localization of lipoprotein-delivered benzoporphyrin derivatiove in the rabbit eye. Curr Eye Res. 1997;16:83-90. 

    상세보기

22. Schmidt-Erfurth U, Flotte TJ, Gragoudas ES, et al. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors Exp Eye Res. 1996;62:1-10. 

    상세보기

23. Miller H, Miller B. Photodynamic theraphy of subretinal neovascularization in the monkey eye. Arch Ophthalmol. 1993;111:855-60. 

    상세보기

24. Cho DY, Bae SH, Han JR, Kim HK, Nam WH. Photodynamic therapy of choroidal neovascularization in age-related macular degeneration with Verteporfin:An analysis of 10 years of clinical results. J Korean Ophthalmol Soc. 2012;53(1)59-67. 

    상세보기

25. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5;355(14):1432-44. 

    상세보기

26. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5;355(14):1419-31. 

    상세보기

27. Jang HJ, Song SJ, Bae JH. Long-Term Effect of Intravitreal Ranibizumab Injection on Choroidal Neovascularization in Age-Related Macular Degeneration. J Korean Ophthalmol Soc. 2013;54(9):1359-64. 

    상세보기

28. Cho YJ, Park SP. Intravitreal Ranibizumab therapy for neovascular age-related macular degeneration with a predominantly hemorrhagic lesion. J Korean Ophthalmol Soc. 2011;52(7):838-45. 

    상세보기

29. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006 Mar;113(3):363-372. 

    상세보기

30. David L, Lincoln V, Dennis O. Cellular models and therapies for age-related macular degeneration. Dis Model Mech. 2015 May 1;8(5):421-7. 

    상세보기

31. Kim MS, Chae JB. Clinical manifestation of retinal pigment epithelial tear after treatment of age-related macular degeneration. J Korean Ophthalmol Soc. 2013;54(10):1540-5. 

    상세보기

32. Park JH, Choae WS, Yoon HS. Long-term observation of retinal pigment epithelial tear after anti-VEGF treatment for age-related macular degeneration. J Korean Ophthalmol Soc. 2013;55(9):1340-6. 

    상세보기

33. Choae WS, Park JH, Lee WS, Kim SW, Yoon HS. Risk Factors for Retinal Pigment Epithelium Tears after Anti-VEGF Agent Injection in Age-Related Macular Degeneration. J Korean Ophthalmol Soc. 2013;45(10:1546-53. 

    상세보기

34. Kim JM, Jang JW, Kyung SE, Chang MH. Macular Hole after Single Intravitreal Injection of Ranibizumab in a Patient with Age-Related Macular Degeneration. J Korean Ophthalmol Soc. 2013;54(7):1130-4. 

    상세보기

35. Ford KM, Saint-Geniez M, Walshe TE, D'Amore PA. Expression and role of VEGF-A in the ciliary body. Invest. Ophthamol. Vis. Sci. 2012;53:7520-7. 

    상세보기

36. Saint-Geniez M, Maharaj ASR, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, et al. Endogenous VEGF is required for visual function: evidence for a survival role on Müuller cells and photoreceptors. PLoS ONE. 2008;3(11):e3554. 

    상세보기

37. Kim SY. Retinal phagocytes in age-related macular degeneration. Macrophage (Houst). 2015;2(1). 

38. Buschini E, Fea AM, Lavia CA, Nassisi M, Pignata G, Zola M, Grignolo FM. Recent developments in the management of dry age-related macular degeneration. Clin Ophthalmol. 2015 Apr 1;9:563-74. 

    상세보기

39. Smailhodzic D, van Asten F, Blom AM, Mohlin FC, den Hollander AI, van de Ven JP, et al. Zinc supplementation inhibits complement activation in age-related macular degeneration. PLoS One. 2014 Nov 13;9(11). 

    상세보기

40. Kil HK, Song YM, Chun KI. The efficacy of Vaccinium Uliginosum for early age-related macular degeneration. J Korean Ophthalmo. 2013;54(8):1255-60. 

    상세보기

41. Heo J. Donguibogam. Bubinmunhwasa. 2009:635. 

42. Ko WS, Kwon K, Kim KJ, Kim KS, Kim YB, Kim JH, et al. Korean Medicine Ophthalmology. 2015:40-41,62,199. 

43. Noh SS. Korean Medicine Ophthalmology, Otolaryngology, dermatology. Seoul Inshuaesa. 2011:339,346. 

저자의 다른 논문 :

정유진 (2) 고우신 (98) 윤화정 (100)